Skip to main content

MCL Status for New Jersey Abilify Litigation

MCL Status for New Jersey Abilify Litigation

MCL Status for New Jersey Abilify Litigation

Introduction

For the ease of management, the New Jersey Supreme Court has granted a Multicounty litigation (MCL) status to Abilify lawsuits filed against Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical Inc. The court transferred 42 pending cases filed originally in various Garden State counties to this multicounty litigation before Judge Nelson C. Johnson of the Atlantic County Superior Court. The request for MCL status was filed in January, viewed to be beneficial to all sides as it would provide a fair and more convenient, cost-effective process.

Over 800 Abilify lawsuits are now a part of the centralized Abilify litigation: MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) formed in the U.S. District Court for the Northern District of Florida, overseen by U.S. District Judge M. Casey Rodgers.  Plaintiffs alleged that the defendants failed to warn the consumers and the medical community about the gambling and other compulsive behavior risks associated with Abilify.

On May 4, a global settlement was announced by Judge Rodgers and all others cases have been put on hold for 120 days while the parties attempt to work out the settlement details.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!